NOVO-NORDISK B ADR/1DK 10NOVO-NORDISK B ADR/1DK 10NOVO-NORDISK B ADR/1DK 10

NOVO-NORDISK B ADR/1DK 10

No trades
See on Supercharts
Market capitalization
‪521.51 B‬EUR
‪11.00 B‬EUR
‪30.53 B‬EUR
‪3.38 B‬
Beta (1Y)
0.53

About NOVO-NORDISK B ADR/1DK 10

CEO
Lars Fruergaard Jørgensen
Headquarters
Bagsværd
Employees (FY)
‪63.37 K‬
Founded
1931
ISIN
US6701002056
FIGI
BBG000JPN0B5
Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.